One case report about multidisciplinary treatment of an advanced multiple primary colorectal cancer

doi:10.3877/cma.j.issn.2095-3224.2016.05.016

Abstract

Abstract:

In recent years, the incidence of colorectal cancer increased significantly, with the multidisciplinary team (MDT) mode is established, the survival time of colorectal cancer and advanced colorectal cancer patients have been significantly extended, the quality of life was effectively improved. The survival of the patient with advanced multiple primary colorectal cancer was 7 years. This patient get better control of the disease and maintain a high quality of life with the comprehensive treatment in MDT model. In this paper, we will report its treatment process and share some experience with you.

Key words: Colorectal neoplasms, Therapy, Multidisciplinary team (MDT), Experience of diagnosis and treatment

Liu Yang. One case report about multidisciplinary treatment of an advanced multiple primary colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(05): 447-449.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2016.05.016

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2016/V05/I05/447

Figures/Tables 1

References 7

[1]	Ng AK,Travis LB.Subsequent malignant neoplasms in cancer surivors[J]. Cancer J, 2008, 14(6): 429-434.
[2]	Travas LB. The epidemiology of second primaTy cancers[J].Cancer Epidemiol Biomarkers Prev, 2006, 15(11): 2020-2026.
[3]	Rozen J P,Liphshtz I,Barchana M. The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods[J].Eur J cancer Prev, 2011, 20(1): 46-53.
[4]	Rosso s,Angelis RD,Ciccolallo L, et a1.Multiple tumours in survival estimates[J].Eur J cancer, 2009, 45(6): 1080-1094.
[5]	White ford MH,Witeford HM,Yee LF, et al.Usefulnese of FDG-PET scan in assessment of suspected metastatic or recurrent adenocarcinoma of colon and rectum.Dis Colon Rectum, 2000, 43(7): 759-767;discussion 767-770.
[6]	Ciardiello F.,Normanno N.,Martinelli1 E., et al. Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX[J].Annals of Oncology, 2016, 11(6) : 1-7.
[7]	Feng Qingyang,Ye Wei,Li Ren, et al. Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study[J].Oncotarget, 2016, 10(7): 11380-11397.

时间	症状	检查	治疗	病情评估	PS评分
2009.2	发现右下腹包块	彩超示双附件囊性包块肿瘤标志物正常	剖腹探查术	CR	2
2009.5-7	无	病理会诊	FOLFOX4方案化疗3周期	SD	2
2009.7-2013.2	无	定期复查	中成药	SD	1
2013.3-5	便血	CEA、CA125升高，PET-CT示乙状结肠直肠交界处放射性浓聚灶，肠镜示距肛门10 cm肿块，病检示高级别上皮内瘤变	剖腹探查术，腹盆腔及腹膜广泛转移	PD	2~3
2013.5-6	便血	CEA、CA125下降，CT示肝多发转移（14 mm）	CPT-11＋L-OHP′1周期	PD	2~3
2013.6-7	乏力	CEA、CA125正常，影像学评估稳定	PTX＋L-OHP′1周期	SD	2~3
2013.7-8	乏力	CEA升高，CT示肝转移（13 mm）	TP′2周期	SD	2
2013.9-12	便血	CEA升高，CT示肝转移瘤增大（18 mm），肠镜示直肠及乙状结肠肿块，活检病理示直肠腺癌，乙状结肠见个别异型腺体	患者一般状况差暂停化疗	PD	2~3
2013.12-2014.4	便血好转	CEA缓慢升高	PTX＋FT-207′4周期	SD	2~3
2014.5-8	便血	CEA、CA125升高，CT示直肠及乙状结肠病灶较前增大	中成药	PD	3
2014.9.11	便血伴肠梗阻	CEA、CA125升高	剖腹探查术＋回肠造瘘术，KRAS基因为野生型	-	2
2014.10-11	无便血	CEA稳定，CT示直肠及乙状结肠病灶无变化	S1化疗2周期	SD	2
2014.12-2015.1	偶有腹痛	CEA升高，CT示直肠及乙状结肠病灶较前增大	S1化疗2周期	PD	1~2
2015.1-3	偶有便血	CEA升高，CT示直肠及乙状结肠病灶较前增大	CPT-11＋S1化疗2周期	PD	2
2015.4-6	偶有便血	CEA下降，CT示直肠及乙状结肠病灶无变化	CPT-11＋雷替曲塞化疗2周期	SD	2
2015.6-8	便血、乏力	CEA下降，CT示直肠及乙状结肠病灶无变化。	CPT-11＋雷替曲塞＋西妥昔单抗治疗2周期	SD	2~3
2015.8-2016.1	偶有腹痛	CEA下降，CT示直肠及乙状结肠病灶无变化	卡培他滨＋西妥昔单抗治疗6周期	SD	2
2015.9.22	肛门坠胀伴肿瘤脱垂	CEA稳定	经肛门局部肿瘤切除术	-	2~3
2016.1-2	无	CEA升高，CT示直肠及乙状结肠病灶增大	卡培他滨＋西妥昔单抗治疗6周期	PD	1
2016.2-3	无	CEA升高，CT示直肠及乙状结肠病灶增大	FOLFIRI＋西妥昔单抗治疗2周期	PD	1
2016.4-至今	下腹部坠胀	CEA稳定，CT示直肠及乙状结肠病灶无变化	FOLFIRI＋贝伐珠单抗治疗2周期	SD	1

时间	症状	检查	治疗	病情评估	PS评分
2009.2	发现右下腹包块	彩超示双附件囊性包块肿瘤标志物正常	剖腹探查术	CR	2
2009.5-7	无	病理会诊	FOLFOX4方案化疗3周期	SD	2
2009.7-2013.2	无	定期复查	中成药	SD	1
2013.3-5	便血	CEA、CA125升高，PET-CT示乙状结肠直肠交界处放射性浓聚灶，肠镜示距肛门10 cm肿块，病检示高级别上皮内瘤变	剖腹探查术，腹盆腔及腹膜广泛转移	PD	2~3
2013.5-6	便血	CEA、CA125下降，CT示肝多发转移（14 mm）	CPT-11＋L-OHP′1周期	PD	2~3
2013.6-7	乏力	CEA、CA125正常，影像学评估稳定	PTX＋L-OHP′1周期	SD	2~3
2013.7-8	乏力	CEA升高，CT示肝转移（13 mm）	TP′2周期	SD	2
2013.9-12	便血	CEA升高，CT示肝转移瘤增大（18 mm），肠镜示直肠及乙状结肠肿块，活检病理示直肠腺癌，乙状结肠见个别异型腺体	患者一般状况差暂停化疗	PD	2~3
2013.12-2014.4	便血好转	CEA缓慢升高	PTX＋FT-207′4周期	SD	2~3
2014.5-8	便血	CEA、CA125升高，CT示直肠及乙状结肠病灶较前增大	中成药	PD	3
2014.9.11	便血伴肠梗阻	CEA、CA125升高	剖腹探查术＋回肠造瘘术，KRAS基因为野生型	-	2
2014.10-11	无便血	CEA稳定，CT示直肠及乙状结肠病灶无变化	S1化疗2周期	SD	2
2014.12-2015.1	偶有腹痛	CEA升高，CT示直肠及乙状结肠病灶较前增大	S1化疗2周期	PD	1~2
2015.1-3	偶有便血	CEA升高，CT示直肠及乙状结肠病灶较前增大	CPT-11＋S1化疗2周期	PD	2
2015.4-6	偶有便血	CEA下降，CT示直肠及乙状结肠病灶无变化	CPT-11＋雷替曲塞化疗2周期	SD	2
2015.6-8	便血、乏力	CEA下降，CT示直肠及乙状结肠病灶无变化。	CPT-11＋雷替曲塞＋西妥昔单抗治疗2周期	SD	2~3
2015.8-2016.1	偶有腹痛	CEA下降，CT示直肠及乙状结肠病灶无变化	卡培他滨＋西妥昔单抗治疗6周期	SD	2
2015.9.22	肛门坠胀伴肿瘤脱垂	CEA稳定	经肛门局部肿瘤切除术	-	2~3
2016.1-2	无	CEA升高，CT示直肠及乙状结肠病灶增大	卡培他滨＋西妥昔单抗治疗6周期	PD	1
2016.2-3	无	CEA升高，CT示直肠及乙状结肠病灶增大	FOLFIRI＋西妥昔单抗治疗2周期	PD	1
2016.4-至今	下腹部坠胀	CEA稳定，CT示直肠及乙状结肠病灶无变化	FOLFIRI＋贝伐珠单抗治疗2周期	SD	1

[1]	The Joint Surgery Branch of the Chinese Orthopedic Association, Guangdong’s Medical Association of Osteoporosis And Bone Mineral Research, Foshan Shunde 3rd Peoele’s Hospital. Clinical intervention guideline for using of anti-osteoporosis drugs in postoperative fragile hip fractures in China (2023 Edition) [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 751-764.
[2]	Zeying Jiang, Anting Wang, Jiaoli Wang, Ci Chen, Qiuling Zhou, Yanjuan Huang, Fang Zhou, Yan Xue, Jianfeng Zhou, Wenyong Tan, Meifang Du. Effect of multiple plant oils combination in preventing the chemoradiotherapy induced toxicities [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(06): 523-527.
[3]	Dechen Wang, Kang Yang, Zijie Yang, Mingbin Gui, Lianping Qu, Xiaofeng Zhang, Feng Gao. Progress of microsatellite stability state and PD-1/PD-L1/IDO in colorectal carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 462-465.
[4]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[5]	Shengjun Zhang, Ajing Zhao, Shoubo Li, Xianghong Hao, Minli Liu. An experimental study on the promotion of colorectal cancer invasion and migration by high glucose through HGF/c-met pathway [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 21-24.
[6]	Yanhui Zhang, Jiao Zhang, Zhixian Zhu. Effect of indwelling anal tube on anastomotic leakage after laparoscopic total mesangectomy after neoadjuvant chemoradiotherapy in patients with middle and low rectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 25-28.
[7]	Ting Li, Lin Zhang. Relationship between serum fatty acid metabolites and vitamin D levels and colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 661-665.
[8]	Bo Kong, Jing Zhang, Ke Lyu. Review on the role of ultrasonography in the diagnosis and treatment of complex ventral hernia [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 670-673.
[9]	Wenkai Ni, Chong Qi, Xiaodan Xu, Xiecheng Zhou, Qingzhang Yin, Yuankun Cai. Analysis of influencing factors of prolonged postoperative ileus in patients with colorectal cancer after operation [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 484-489.
[10]	Xiaoyu Fan, Sizheng Sun, Yimin E, Chunzhao Yu. Different surgical options for obstructive left colon cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 500-504.
[11]	Huiying Ma, Xinling Fan, Shirui Tan, Jiayun Chen, Ying Cao, Yuan Xu, Jing Jin, Yuan Tang. Magnetic resonance linac for locally advanced rectal cancer: a preliminary experience [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 519-523.
[12]	Guangjun Zhong, Chunhua Liu, Wansen Zhu, Xiaolei Xu, Zhaojun Wang. Application of conventional MRI combined with different scanning sequences in preoperative staging diagnosis, chemotherapy efficacy and prognosis evaluation of gastric cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 378-382.
[13]	Qiujie Shan, Lizhu Sun, Yiquan Xu, Zhixia Wang, Yan Xu, Hao Ma, Tiantian Liu. Construction and application of radiation-induced lung injury risk model for middle-aged and elderly patients with esophageal cancer during intensity modulated radiotherapy [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 388-393.
[14]	Ruixue Yue, Lingxin Kong, Xin Hao, Jinqiang Yang, Meng Han, Guozhong Cui, Jianjun Wang, Zhisheng Zhang, Fanting Kong, Wei Zhang, Wenbo He, Xianqiao Li, Xinping Zhou, Donghong Xu, Chongzhu Hu. HER2 protein expression levels predict efficacy of neoadjuvant therapy in breast cancer: A real-world study [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 765-770.
[15]	Yingqian Li, Huashan Li. Evaluation of treatment methods for complete rectal prolapse: a real world study [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 700-705.

Please choose a citation manager

Content to export